Where Does Qiagen NV (QGEN) Stock Fall in the Diagnostics & Research Field After It Is Down -1.06% This Week?

Qiagen NV (QGEN) is around the top of the Diagnostics & Research industry according to InvestorsObserver. QGEN received an overall rating of 63, which means that it scores higher than 63 percent of all stocks. Qiagen NV also achieved a score of 92 in the Diagnostics & Research industry, putting it above 92 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 65 out of the 148 industries.

QGEN has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on QGEN!

See Full QGEN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Qiagen NV Stock Today?

Qiagen NV (QGEN) stock is down -1.52% while the S&P 500 is higher by 1.46% as of 12:54 PM on Wednesday, Dec 1. QGEN is down -$0.84 from the previous closing price of $55.11 on volume of 462,179 shares. Over the past year the S&P 500 has gained 26.52% while QGEN is higher by 11.99%. QGEN earned $2.56 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 21.21. Click Here to get the full Stock Report for Qiagen NV stock.